Ministry for Health

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Istituto di Fisiologia Clinica意大利5
2. University of Ferrara意大利5
3. University of Ulster英国5
4. Provincial Institute for Hygiene比利时4
5. Otto-von-Guericke-Universität Magdeburg德国4
6. Health Service Executive爱尔兰4
7. Centre Hospitalier Universitaire Vaudois瑞士4
8. University Medical Center Groningen荷兰4

按月发文

逐年被引

最新文献

1. 1
   Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control StudyDrug Safety20260
2. 2
   The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in PregnancyPharmacoepidemiology and Drug Safety20260
3. 3
   ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022Pharmacoepidemiology and Drug Safety202215
4. 4
   Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of ReferenceDrug Safety202115
5. 5
   Drug safety in thalassemia: lessons from the present and directions for the futureExpert Opinion on Drug Safety20215
6. 6
   Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control StudyDrug Safety201760

高被引文献

1. 1
   Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control StudyDrug Safety201760
2. 2
   ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022Pharmacoepidemiology and Drug Safety202215
3. 3
   Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of ReferenceDrug Safety202115
4. 4
   Drug safety in thalassemia: lessons from the present and directions for the futureExpert Opinion on Drug Safety20215

主要发表期刊